| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.0029 | 1 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |